428 related articles for article (PubMed ID: 19070992)
1. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
[TBL] [Abstract][Full Text] [Related]
2. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
Sood R; Rao M; Singhal S; Rattan A
Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
[TBL] [Abstract][Full Text] [Related]
3. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives.
Santos JL; Yamasaki PR; Chin CM; Takashi CH; Pavan FR; Leite CQ
Bioorg Med Chem; 2009 Jun; 17(11):3795-9. PubMed ID: 19427791
[TBL] [Abstract][Full Text] [Related]
5. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
Abate G; Koivula T; Hoffner SE
Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
[No Abstract] [Full Text] [Related]
8. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
[TBL] [Abstract][Full Text] [Related]
12. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
13. Ring-substituted imidazoles as a new class of anti-tuberculosis agents.
Gupta P; Hameed S; Jain R
Eur J Med Chem; 2004 Sep; 39(9):805-14. PubMed ID: 15337293
[TBL] [Abstract][Full Text] [Related]
14. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases.
Camacho-Corona Mdel R; Ramírez-Cabrera MA; Santiago OG; Garza-González E; Palacios Ide P; Luna-Herrera J
Phytother Res; 2008 Jan; 22(1):82-5. PubMed ID: 17726732
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
[TBL] [Abstract][Full Text] [Related]
16. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
